Breadcrumb Home News News Azithromycin favored over roflumilast for protecting against COPD exacerbations Azithromycin favored over roflumilast for protecting against COPD exacerbations August 19, 2026 1 min read William Feldman, MD: Azithromycin Over Roflumilast in Real World COPD Data William Feldman, MD: Azithromycin Over Roflumilast in Real World COPD Data August 19, 2026 1 min read Good News — Researchers Just Found Which Drug Is Better to Treat COPD Flare-Ups COPD is becoming more common in women and is a major risk factor for lung cancer. August 11, 2026 1 min read Umeclidinium-vilanterol shows modest but consistent advantage among LAMA-LABA options in symptomatic COPD Umeclidinium-vilanterol shows modest but consistent advantage among LAMA-LABA options in symptomatic COPD May 06, 2026 1 min read Lawmakers say a monopoly is worsening U.S. physician shortage Lawmakers say a monopoly is worsening U.S. physician shortage April 17, 2026 1 min read COPD exacerbation risk falls with dry powder vs. metered-dose, soft mist inhaler COPD exacerbation risk falls with dry powder vs. metered-dose, soft mist inhaler March 18, 2026 1 min read Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says Asthma patients suffered as GSK pursued ‘egregious’ price hikes, senator says March 16, 2026 1 min read Strait of Hormuz standoff puts supply of America’s generic drug prescriptions at risk Strait of Hormuz standoff puts supply of America’s generic drug prescriptions at risk March 16, 2026 1 min read Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD Umeclidinium-Vilanterol Tied to Better Outcomes Than Other LAMA-LABA Inhalers in Symptomatic COPD February 25, 2026 1 min read Dry Powder Inhalers: A Double Win for COPD and Environment Dry Powder Inhalers: A Double Win for COPD and Environment February 24, 2026 1 min read Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access December 09, 2025 1 min read